Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 118

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 118
---
 in the Purchase Agreement, which conditions include, among others, the following:

| • | the accuracy in all material respects of our representations and warranties included in the Purchase Agreement; |

| • | us having performed, satisfied and complied in all material respects with all covenants, agreements and                                
 conditions required by the Purchase Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by us; |

| • | the absence of any material misstatement or omission in the registration statement that includes this 
 prospectus;                                                                                           |

| • | this prospectus, in final form, and all reports, schedules, registrations, forms, statements, information                                 
 and other documents required to have been filed by us with the SEC pursuant to the reporting requirements of the Exchange Act having been 
 so filed;                                                                                                                                 |

| • | the Depositary Shares not having been suspended by the SEC, NASDAQ or FINRA and there not having been                        
 imposed any suspension of, or restriction on, accepting additional deposits of common stock by The Depository Trust Company; |

| 58 |

| • | no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as defined in 
 the Purchase Agreement) shall have occurred and be continuing;                                          |

| • | customary compliance with laws and bankruptcy-related conditions; and |

| • | the receipt by the Selling Shareholder of customary legal opinions, as required under the Purchase Agreement. |

Termination of the Purchase Agreement

Unless earlier terminated
as provided in the Purchase Agreement, the Purchase Agreement will terminate automatically on the earliest to occur of:

| • | the first day of the month next following the 36-month anniversary of the Commencement Date; |

| • | the date on which the Selling Shareholder shall have purchased the Commitment Amount; |

| • | the 90th day after the date on which, pursuant to or within the meaning of any bankruptcy law, we commence                            
 a voluntary case or any person commences a proceeding against us, in each case that is not discharged or dismissed prior to such 90th 
 day; and                                                                                                                              |

| • | the date on which, pursuant to or within the meaning of any bankruptcy law, a custodian is appointed for              
 us or for all or substantially all of our property, or we make a general assignment for the benefit of our creditors. |

We have the right to terminate
the Purchase Agreement at any time after Commencement Date, at no cost or penalty, upon one business day’s prior